INTRODUCTION
Neural tube defects (NTDs) are the second most common congenital anomaly in humans, affecting 1 -2 babies per 1000 births (1) . NTDs arise from failure of the neural tube to close during the third to sixth week of gestation and impose a life-long burden on the affected patients and on society (2) . The neural tube arises from the neural plate through a series of complex cellular behaviors that underlie directional cell motility, shaping, bending and fusion of the neural tube (1) . Failure of neural tube closure can occur at any axial level causing 'open' or 'closed' NTDs. Open NTDs arise from failure of the neural tube to close in any but the most caudal portion of the neural tube and include lethal forms such as the relatively common anencephaly (at the most rostral part of the brain) and the rare craniorachischisis (an open NTD from the midbrain -hindbrain junction along the entire spinal cord axis). In the most common open NTD, spina bifida (myelomeningocele), patients survive but endure greatly diminished quality of life, suffering from both the consequences of NTDs and associated pathologies. NTD defects found at the caudal body limit comprise the 'closed' NTDs.
Population and genetic studies indicate that both environmental and genetic factors contribute to the pathogenesis of NTDs (3 -5) ; inheritance patterns appear to be polygenic (6) . Due to the complex etiology of NTDs and the scarcity of large cohorts, the identification of NTD genes has proven to be very difficult. However, in the last decade, the study of .150 mouse genetic models has implicated specific genes in the pathogenesis of NTDs and has recently helped identify mutations in VANGL1 and VANGL2 genes as a cause of human NTDs (7 -10) . Thus far, 13 rare heterozygous mutations in VANGL1 and 9 additional mutations in VANGL2 have been documented in open and closed human NTDs; collectively, mutations in VANGL genes are estimated to account for 0.4-2.5% of NTDs in humans (7 -10) , indicating that other mutant genes must account for most of the cases.
Vangl1 and Vangl2, homologs of the Drosophila gene, Van Gogh, encode proteins in the planar cell polarity (PCP) pathway (11) (12) (13) . In flies, PCP is evident in the uniform orientation of hairs on the wing or in the pattern of ommatidia in the multifaceted eye (14) . In vertebrates, the PCP pathway has been adapted to a wide array of cellular processes (15) . During neurulation, PCP signaling organizes actin-based cellular protrusions (lamellipodia) in cells of the neural plate, enabling cells to move medio-laterally and intercalate with each other. This directional cell movement causes neural plate extension along the anterior -posterior axis with concomitant narrowing in the perpendicular direction, a process known as convergent extension (16) . Narrowing of the neural plate enables the lateral neural folds to oppose and fuse. In mice, heterozygous mutations in Vangl2 produce a characteristic mild closed NTD-'looped tail' (13, 17, 18) , but homozygous ablation of Vangl2 or Vangl1 (low penetrance) or compound heterozygosity for Vangl2 +/2 /Vangl1 +/2 results in craniorachischisis and death in utero (13, 19, 20) .
The PCP gene, Fuzzy, was also originally discovered in Drosophila, where it was reported to regulate hair polarity in a restricted set of fly tissues (11, 21, 22) . In Xenopus laevis, knockdown of Fuzzy (XFy) results in an open neural tube along the entire spinal axis, associated with body shortening, disruption of the cortical actin network and sparse rudimental cilia in skin cells (23) . A recently published gene-trap Fuzzy knockout (KO) mouse exhibits severe cranial NTD, exencephaly, severely dilated brain ventricles and looped tail as well as defects of the cardiac outflow tract, hypoplastic lungs and polydactyly (24, 25) . Importantly, the phenotype of Fuzzy mice appears to overlap with that of the Lp mouse (looped tail and similar cardiac outflow defects). Based on its role in planar polarity in flies and neural tube formation in vertebrates, we reasoned that Fuzzy mutations might also account for NTDs in humans.
Originally, the fly Fuzzy gene was reported to encode a novel tetraspan transmembrane protein (21) . However, recent in silico analysis and functional assays performed in Xenopus laevis argue that Fuzzy protein more likely encodes a putative LONGIN domain protein (24) . Thus, it is difficult to surmise much about the cellular function of Fuzzy from its predicted molecular structure.
In the present manuscript, we report the identification of five non-synonymous amino acid changes within the FUZZY coding sequences that were found only in NTD patients, but not in controls. Three of these changes affect evolutionarily conserved residues. We have developed functional assays to determine whether these FUZZY mutations affect ciliogenesis and directional cell movements. In view of the Fuzzy expression pattern during neurulation, the NTD phenotype of Fuzzy mutant mice, and the impact of mutations on cilia formation and directional cell movements, we propose that FUZZY mutations may account for a subset of human NTDs.
RESULTS
Fuzzy is expressed during neural tube closure E14.5 Fuzzy gt/gt mutants display exencephaly and looped tail (Fig. 1A) . In neurulating E8.5 days post-coitum (dpc) embryos, we detected Fuzzy mRNA in the emerging neural tube along its entire anterior -posterior axis ( Fig 1B) ; the highest level was identified in the rostral part and cervical area (Fig. 1B, arrow) . At E8.5 and E9.5 embryos, Fuzzy mRNA was detected in the notochord and floor plate, where convergent extension movements of neuroepithelium regulated by PCP have taken place ( Fig. 1B and C ; nc, notochord, nt, neuroepithelium). By E9.5, Fuzzy mRNA level had substantially decreased, but was still detectable in midline structures of the spinal cord and at a low level throughout the neural tube (Fig. 1C , small and large arrowheads, respectively, AS probe). In addition, Fuzzy mRNA expression had spread to facial structures and was detected at high level in the forebrain and midbrain (Fig. 1D, arrows) .
Fuzzy sequence variants are found in a cohort of patients with NTDs
Among 234 Italian patients with NTDs, we detected a total of five disease-associated sequence variants which involved nonconservative amino acid substitutions (Fig. 2, Table 1 ). These sequence variants were absent in 130 matching Italian controls and over 250 control subjects sequenced as a part of the Genome 1000 database (http://www.1000genomes.org/page.php, last accessed 8-4-10). We evaluated the potential pathogenicity of each putative mutation based on the following criteria: (a) nature of the amino acid substitution; (b) evolutionary conservation of the affected residue among Fuzzy proteins of various species; (c) segregation with additional members of the family; (d) correspondence between the patient's clinical presentation and sites of Fuzzy expression in the developing mouse or the phenotype of the Fuzzy mutant mice; (e) the impact of each mutation on cilium formation or directional cell movements in vitro.
p.Pro39Ser substitution (Fig. 2B ) was identified in a child born to healthy parents. Sequence analysis of the DNA of both mother and father showed that the p.Pro39Ser variant was absent, suggesting that pPro39Ser is potentially a de novo mutation. The patient was born at 31 weeks of gestation and presented with myelomeningocele at L5-S2 level, Chiari II malformation and hydrocephalus. The Proline at codon 39 in the second exon is a highly conserved amino acid, present in all species examined except frogs (Fig. 2C) .
The variant, p.Asp354Tyr (Fig. 2B) , was identified in a female born in Sicily from consanguineous parents. The patient presented with lumbo-sacral myelomeningocele, Chiari II malformation and hydrocephalus. The same p.Asp354Tyr substitution was found in the father of the affected child and was absent in the mother. p.Asp354Tyr substitution affects a highly evolutionary conserved residue, which is identical in all except one species (frog) (Fig. 2C) . Replacement of the acidic aspartic acid residue by the uncharged, nonpolar tyrosine amino acid in the affected patient is non-conservative.
p.Arg404Glu substitution (Fig. 2B ) was identified in a Caucasian sporadic male who presented with an ulcerated lumbar hemimyelomeningocele, diastematomyelia, triventricular hydrocephalus and Chiari II malformation. Audiometric testing revealed associated moderate transmissive deafness. The arginine at codon 404 is highly conserved in all species examined and maps to the C-terminus of the Fuzzy protein, within a predicted alpha-helix of the LONGIN domain ( Fig. 2A and C) . The arginine (basic amino acid) to glutamine (uncharged residue) substitution introduces a shorter side chain with a protonated nitrogen into the helix-organized domain and removes a potential oxygen acceptor ion important for the hydrogen-oxygen interactions.
p.Gly140Glu and p.Ser142Thr were found in two sporadic cases of NTDs: one with the caudal regression syndrome (closed NTD) and another with myelomeningocele (open NTD), respectively ( Fig. 2 , Table 1 ). In Fuzzy sequence, both p.Gly140Glu and p.Ser142Thr are predicted to be well-tolerated by the protein structure according to SIFT and PolyPhen. In fish and flies, Glycine at the position 140 is replaced by Glutamic acid and, in frogs, Serine at the position 142 is substituted for Threonine, suggesting that these two changes are most likely non-pathogenic. Additional rare non-synonymous and synonymous single nucleotide polymorphisms (SNPs) detected in both patients and controls are listed in Table 2 .
Putative mutations in NTD patients impact Fuzzy-regulated ciliogenesis and directional cell movement
At the present time, little is known about Fuzzy function. However, Fuzzy appears to influence ciliogenesis in neuroepithelial and skin cells of mice and frogs (23) (24) (25) (26) . We, therefore, tested whether the three potentially pathogenic Fuzzy mutations p.Pro39Ser (Fuzzy39), p.Asp354Tyr (Fuzzy354) and p.Arg404Gln (Fuzzy404) associated with human NTDs have an impact on ciliogenesis. We first established cultures of immortalized mouse embryonic fibroblasts (MEFs) from wild-type and homozygous Fuzzy gt/gt E12.5 embryos. When grown to confluency in the low-serum medium, 40% of wild-type MEFs display primary cilia (data not shown), whereas homozygous mutant MEFs 2/2 lack cilia entirely ( transfected with wild-type Fuzzy; the average length of cilia in Fuzzy404-expressing cells was also significantly shorter (1.86 + 0.15 mm) than FuzzyWT-transfected controls (2.17 + 0.35 mm), P , 0.001. None of the other putative mutants had a significant effect on cilia length.
To validate these results, we used an alternative assay involving the epithelial MDCKII cell line, derived from canine renal collecting duct. These cells form primary cilia in post-confluent cultures (27) .To test whether Fuzzy influences ciliogenesis in MDCK cells, we established independent clones stably expressing GFP-FuzzyWT or GFP (control) expression vectors. Overexpression of the wild-type Fuzzy protein led to a dramatic increase in the percentage of ciliated cells and an increase in average ciliary length (Fig. 3C -E) . To assess the impact of potential human Fuzzy mutations on this phenomenon, we generated stable MDCK clones transfected with Fuzzy39, Fuzzy354 and Fuzzy404 expression vectors and confirmed stable expression of wild-type or mutant GFP-Fuzzy proteins by western immunoblotting. For further analysis, we chose clones with comparable protein expression levels (Fig. 3D) . We calculated the percentage of cells exhibiting primary cilia and measured mean ciliary length of elongated cilia in comparison to cells transfected with wild-type Fuzzy. Again there was no effect of any mutant on the percentage of ciliated cells (Fig. 3E) , however MDCK cells expressing Fuzzy404 or Fuzzy354 had significantly fewer cells with elongated (.3 mM) cilia compared with cells transfected with Fuzzy wild-type (Fig. 3F ). Among cells with elongated cilia, average ciliary length was significantly reduced in Fuzzy404 (6.93 + 2.34 mm) compared with FuzzyWT (11.38 + 3.4 mm) cells (Fig. 3G) .
Since Fuzzy has been reported to regulate the actin cytoskeleton in Drosophila and Xenopus, we reasoned that it might exert influence on directional cell movement. If so, the effect of wildtype and mutant Fuzzy proteins might be distinguished with in vitro scratch assays. To test this possibility, we made a scratch in confluent MDCK cells expressing wild-type and mutant Fuzzy proteins and measured the percent of the original scratch area unoccupied by cells after 10 h. In MDCK cells overexpressing wild-type Fuzzy, the unoccupied scratch area was significantly increased compared with cells transfected with the empty vector (Fig. 3H, lane 2) . However, MDCK cells overexpressing Fuzzy 404 had no such effect on movement of cells into the wound, and the cell movement was comparable with that in control cells expressing only GFP protein (Fig. 3H, lane 5) . Interestingly, the unoccupied scratch area was dramatically decreased in two separate MDCK clones expressing Fuzzy 39 and in two separate clones expressing Fuzzy354 (Fig. 3H,  lanes 3 and 4, respectively) .
DISCUSSION
This is the first report describing mutations of the PCP gene, FUZZY, among human patients with NTDs. The relevance of FUZZY to neural tube formation is evident from the following: (i) gene-trap Fuzzy homozygous mouse mutants exhibit a spectrum of NTDs ranging from exencephaly to looped tails; (2) neuronal specification in the spinal cord of Fuzzy gt/gt mice is abnormal, confirming that Fuzzy participates in developmental events along the entire neural axis (25) ; (3) we detected dynamic Fuzzy mRNA expression in the emerging neural tube and notochord along its rostro-caudal axis. Taken together, these observations indicate an important role for FUZZY in neural tube formation.
Since the causes of most human NTDs are unknown, we screened a well-defined cohort of human 234 Italian patients with NTDs for putative FUZZY mutations. Five FUZZY variants were identified that changed an amino acid and were absent in 130 Italian and more than 250 international controls. Our in silico analyses predicted that the Fuzzy404 and Fuzzy354 mutations might disrupt protein function, whereas the others were more likely benign polymorphic variants. The pathogenic nature of the Fuzzy404 mutation was confirmed in two novel independent in vitro assays which assess the importance of Fuzzy for ciliogenesis.
p.Arg404Glu was found in one of the parents of the index case, suggesting that the mutation exhibits incomplete penetrance. Similarly, incomplete penetrance of VANGL1 and VANGL2 mutations in NTD patients has been previously reported, suggesting that additional modifier genes and/or environmental factors may be required to unmask their effects (7, 9) . Conceivably, our patients carry a mutation in some non-coding regulatory region of the other FUZZY allele or the NTD phenotype may be due to an interaction between the heterozygous FUZZY mutation and another mutant gene in the same developmental pathway. Consistent with this idea, we and others noticed a wide spectrum of NTD phenotypes in the Fuzzy gt/gt mice: some embryos in the same litter exhibited an encephalocele, while others appeared to have only enlarged ventricles or a looped tail (24; unpublished data).
Previous in silico analysis of frog Fuzzy indicates that the c-terminal 128 amino acids contain a LONGIN domain (24) , often found in proteins belonging to the vesicular trafficking Genome 1000 frequency ¼ 1 -15% depending on the ethnic group studied (890 chromosomes sequenced).
f Genome 1000 frequency ¼ 1% average (520 chromosome sequenced). network (28) . Our observations on the role of Fuzzy in MEFs and MDCK cells, where it behaves as a critical regulator of ciliogenesis, are compatible with experimental evidence in Xenopus laevis, suggesting that Fuzzy participates in polarized vesicular traffic to the base of the primary cilium (24) . The p.Arg404Glu mutation in Fuzzy protein causes a significant reduction in the cilial length in assays which specifically capture Fuzzy-dependent assembly of the primary cilium. Since formation of the primary cilium depends on polarized vesicular traffic to its basal body (29, 30) , we hypothesize that this mutation disturbs vesicular delivery of proteins that support ciliogenesis. Fuzzy was originally identified in a mutational screen in Drosophila (21) and found to interact genetically with other PCP proteins that relay signals to the actin cytoskeleton (31) . Likewise, in Xenopus, Fuzzy was reported to control actin network of epidermal cells (23) . When mammalian PCP genes are either lost or overexpressed, directional cell movements are disturbed (32 -34) . In scratch assays, we found that overexpression of wild-type Fuzzy in MDCK cells slowed movement into the wound. However, this effect was not seen with Fuzzy404. Interestingly, in MDCK cells, Fuzzy39 and Fuzzy354 actually accelerated cell movement, leaving only a small percentage of the scratch unoccupied by cells after 10 h. Taken together, our observations suggest two functional classes of human FUZZY mutations affecting either ciliogenesis or directional cell movement.
Since some FUZZY mutations appear to effect PCP pathway functions, we reasoned that some NTD patients might harbor mutant Fuzzy alleles in combination with other mutant PCP genes, such as VANGL1 or VANGL2. Indeed, the frequency of FUZZY mutations ( 0.8%) is similar to the reported frequency of pathogenic mutations identified in VANGL1 or VANGL2 genes (0.4 -2.5%) (7). However, the FUZZY mutations identified here were independent of the VANGL1 or VANGL2 mutations previously described in this same cohort.
In summary, we have identified the first putative mutations of the human PCP gene, FUZZY, in NTD patients. We demonstrate that the p.Asp404Glu mutation interferes with ciliogenesis in two independent assays, but fails to modulate cell directional movement above control. Conversely, the p.Pro39Ser mutations had a striking effect on directional cell movement without affecting ciliogenes. Dysfunction of the p.Asp354Tyr mutant was detected in both assays. We propose that FUZZY mutations may contribute to a subset of human NTDs.
MATERIALS AND METHODS

Patients
A total of 234 DNA samples were derived from the NTD patient cohort at the Spina Bifida Center of the Gaslini Hospital in Genova, Italy. All samples were obtained with informed consent of patients and their families according to the requirements of the Ethics Committee at the Gaslini Hospital. All patients in this study display isolated, open or closed NTDs. The patients are part of a subset of cases previously analyzed for mutations in the VANGL1 and VANGL2 genes (7, 8) . The control cohort consisted of 130 Italian children and young adults admitted to the Gaslini Hospital for miscellaneous reasons and chosen randomly for the purpose of this study and Genome 1000 SNPs database (http ://www.1000genomes.org) which lists genetic variants that have frequencies of at least 1% in the populations studied. Genome 1000 database includes DNA samples from 28 human ethnic populations including 396 DNA samples of European ancestry that have already been analyzed.
Sequencing
The single-copy FUZZY gene is spanning 5.6 kb (GenBank NC_000019.9; ID:80199) on chromosome 19q13.33, FUZZY transcript comprises 11 exons (1.67 kb mRNA sequence, GenBank NM_025129). Six genomic DNA fragments corresponding to the FUZZY coding sequence and exon-intron junctions were PCR-amplified, sequenced with the ABI Prism Big Dye System and run on an ABI 3700 automated sequencer [McGill University Genome Quebec Innovation Centre (MUQGIC)]. Initially, all samples were sequenced with either a specific Forward or Reverse primer. All mutations were then confirmed by repeating PCR reactions, followed by re-sequencing of both DNA strands. DNA samples from parents were obtained where indicated in the text and sequenced in both directions. The primer sequences are available upon request. Identified amino acid substitutions were analyzed in silico by SIFT (Sorting Intolerant From Tolerant Program, http://sift.bii.a-star.edu.sg/) and PolyPhen (Polymorphism Phenotyping http://genetics.bwh.harvard.edu/pph2/) to predict a potential damaging versus benign effect on protein function.
Plasmids
The human Fuzzy cDNA fused to the FLAG tag at its C-terminus was synthesized by GenScript (NJ, USA) in pcDNA3.1. The disease-associated amino acid changes were generated by PCR-based mutagenesis using wild-type human Fuzzy cDNA as a template and referred for convenience as 'mutants'. Following primers were used: hFuzzy-Forward-
Restriction sites incorporated into the sequences are underlined, and the mutated nucleotides are shown in bold. The wild-type and mutant cDNAs were cloned in-frame into pEGFP-C1 (Clontech) using KpnI and BamHI restriction sites at N-and C-termini to generate GFP-Fuzzy expression constructs. Integrity and presence of all mutations in the resultant constructs were confirmed by direct double-strand sequencing.
In situ hybridization
Embryos (E7.5-E9.5) from timed CD1 pregnancies were dissected and preserved as described in reference (35) for the whole-mount in situ hybridization (WISH) studies. A murine 610 bp Fuzzy cDNA fragment (4 -614 bp) was generated by reverse transriptase -polymerase chain reaction using embryonic E13.5 brain tissues as a source of mouse Fuzzy mRNA and cloned into pBluescript KS+ (Stratagene) using EcoRI and HindIII flanking restriction sites incorporated into cloning primers: mFuzzy-IS-Forward 5 ′ -CATAG CGAATTCGGGG ATGAGGGGCCGGGAAGC-3 ′ ; mFuzzy-IS-Reverse 5
′ -ATCAGTAAGCTTTCAGAG GAGCGGGG TGAGGGC-3
′ . The integrity of the Fuzzy fragment was confirmed by sequencing. Sense and antisense cRNA probes were synthesized and labeled with the digoxigenin by using the digoxigenin-labeling kit as described by the manufacturer (Roche Diagnostics). WISH was performed as described in reference (35) .
Generation of Fuzzy mutant mouse
Fuzzy transgenic mice were produced at the McGill Transgenic Facility from the ES cell line AN0439 (www.genetrap.org). The phenotype of the Fuzzy KO mice was similar to that described by Liu's group (25) . Homozygous mice were obtained by brother:sister mating of viable heterozygous mice. Appearance of the plug was considered 0.5 dpc. Timed-pregnant females were sacrificed at various developmental stages to obtain embryos. Genotyping was carried out with the following primers: wild-type allele: mFuzzyForward 5
′ -CACCTCTGAGCTGAGGCTGG-3 ′ ; mFuzzyReverse 5
′ -CTCAATTCTTTCTTCAGTCTTTC-3 ′ ; trapped allele: bGEO-1F 5
′ -TTATCGATGAGCGTGGTGGTTAT GC-3 ′ ; bGEO-2R 5 ′ -GCGCGTACATCGGGCAAA TAAT ATC-3 ′ .
Mouse embryonic fibroblasts
MEFs were established from E12.5 Fuzzy mutant littermates of three genotypes: +/+, +/2 and 2/2. Briefly, embryos were microdissected and heads, hearts and livers were removed. The remaining tissues were washed with warm Dulbecco's modified eagle medium (DMEM) medium supplemented with 1% penicillin/streptomycin (Wisent) and 1% fungizone (Wisent), minced and incubated with 0.5 ml of 0.5% trypsin (Wisent) overnight at 48C, followed by 30 min incubation at 378C. Ten milliliters of fresh DMEM medium supplemented with 10% fetal bovine serum (FBS) was added and tissues were triturated by sequential pipetting with 5 and 10 ml serological pipettes, washed twice in the culture medium and plated into T175 tissue culture flasks. Cells were grown to 80-90% confluency (passage one) and split into T75 flasks. Cells were immortalized with E6/E7 antigen as described in reference (36) . The conditioned medium containing E6/E7 proteins was kindly provided by Dr Paul Goodyer (McGill University). The immortalization procedure was repeated three times on the same cells and, by passage 6, MEFs grew evenly and appeared homogenous in culture.
Transfections and cilia analysis
MEFs 2/2 and MEFs +/+ were plated at 10 5 per cm 2 into 12-well plates (Sarstedt) containing collagen-coated cover slips and cultured in DMEM medium as above. Twenty four hours later, the FBS content was reduced to 0.5% to slow growth and induce generation of cilia. Cells were analyzed 48 h later for the presence of a primary cilium visualized by indirect immunofluorescence with monoclonal anti-acetylated-alpha-tubulin antibody (Sigma) and donkey anti-mouse Alexa546 (Molecular probes); nuclei were stained with 4 ′ ,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Z-stacks of the random frames to capture .1000 cells per genotype were taken using AxioObservor 100 (Zeiss) to ascertain percentage of ciliated cells as fraction of total cells. For transfections, immortalized MEFs 2/2 were seeded on glass cover slips and cultured for 24 h as above (six replicas for each plasmid). Transient transfections were carried out using FuGene6 (Roche) as recommended by the manufacturer, with 750 ng/well of plasmid DNAs. Two wells per plasmid were additionally transfected with 250 ng of Renilla-Luciferase (Promega) to monitor for transfection efficiency. After 4 h post-transfection, medium was replaced with DMEM supplemented with 0.5% FBS to induce ciliogenesis. Seventy two hours later, cells were fixed and analyzed for the presence of cilia as above. Over 800 cells were scored for each cDNA; results are reported as the percent of cell bearing a cilium to the total cells. Luciferase activity was measured by Dual Luciferase reporter Assay Kit (Promega) as recommended by manufacturer to normalize transfection efficiency. Ciliary length was measured in .150 cells per construct using Axiovision Ref 4.8 software (Zeiss); the mean cilial length and percentage of cells with cilia ≤1 mm were calculated. Transfections were performed three times.
Madin-Darby Canine Kidney epithelial cells, MDCKII, were seeded in six-well plates and grown in DMEM supplemented with 10% FBS and 1% P/S/F. The cells were transfected with 0.5 mg GFP-tagged wild-type and mutant Fuzzy expression constructs using Lipofectamine 2000 (Invitrogen) as recommended by the manufacturer. The next day, the cells were transferred to 100 mm Petri dishes and 800 mg/ml Neomycin (Invitrogen) was added. After 2 weeks in culture, individual neomycin-resistant clones were expanded and analyzed for Fuzzy expression (see below). Five Fuzzy+ clones per wild-type or mutant constructs were analyzed for cilia formation. Cells for each clone were plated on cover slips in quadruplicate at 15 × 10 5 /well and grown as above. After 10 days, cells were fixed in 4% paraformalidehyde and analyzed for the presence of a primary cilium as above. To facilitate cilia counting and demarcate the plasma membrane, cell -cell contacts were labeled with anti-ZO-1 antibody (Zymed) and nuclei were labeled with DAPI (Invitrogen). More than 3000 per clone were counted independently by two researchers in three independent experiments. Cells with a dot-like (≤3 mm) cilia were designated as 'nucleated'; cells with cilia .3 mm were designated as 'elongated'. The percentage of nucleated and elongated cells per individual clone is presented as a fraction of total ciliated cells. Precise ciliary length in cells with elongated cilia was measured in .200 cells per clone as above and average ciliary length was calculated.
Western immunoblotting
MDCK cells stably expressing various Fuzzy constructs or HEK293 cells transiently transfected with the same constructs were lysed in PLC buffer containing 50 mM Hepes (pH 7.5), 150 mM NaCl, 10% glycerol, 0.5% Triton X-100, 1.5 mM MgCl 2 , 1 mM ethylene glycol tetraacetic acid, 2 mM Na 2 Vanadate, 10 mM Na 2 Pyrophosphate, 25 mM NaF, 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Bioshop). Fifty micrograms of the whole cell lysate from each clone for each cDNA were resolved on 10% polyacrylamide gel electrophoresis -sodium dodecyl sulfate gel and probed with monoclonal anti-GFP (Santa Cruz) or FLAG (Sigma) antibodies followed by anti-mouse horseradish peroxidase-conjugated antibodies (Jacksons labs) and detected with the West Pico ECL kit (Thermo Scientific).
Wound assay
MDCK cells overexpressing wild-type or mutant Fuzzy proteins were plated into six-well plates and grown as above to confluency for 24 h and then exposed to low-serum (1% FBS) medium for additional 24 h. A wound was scratched on the culture surface and cells were photographed at 0 and 10 h after start of the experiment. Twelve images per time point per well were acquired using AxiObservor-100 microscope (Zeiss). For each image, the surface area within a wound unoccupied by the cells after 10 h was measured using Outline Spline (mm 2 ) Interactive Measurement program (Zeiss). Experiments were repeated twice with two independent clones of each Fuzzy cDNA or control cell line.
Statistical analysis
We conducted one-way analysis of variance statistical test, followed by a priori t-tests (ciliary lengths, percentage of ciliated cells, wound assays). We used the Chi-square test to analyze ratios of long/short or nucleated/elongated cilia in cells expressing Fuzzy mutants versus wild-type Fuzzy.
